• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: W.L. GORE & ASSOCIATES GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

W.L. GORE & ASSOCIATES GORE® CARDIOFORM SEPTAL OCCLUDER; TRANSCATHETER, SEPTAL OCCLUDER Back to Search Results
Catalog Number GSX0025A
Device Problem Insufficient Information (3190)
Patient Problems Cardiac Perforation (2513); Pericardial Effusion (3271)
Event Date 03/06/2018
Event Type  Injury  
Manufacturer Narrative
A review of the manufacturing records verified the lot was processed normally and all pre-release specifications were met.(b)(4).
 
Event Description
It was reported the physician selected a 25 mm gore® cardioform septal occluder to close a patent foramen ovale.A j-tip guidewire and multipurpose catheter were used to access the defect.The physician attempted to place the guidewire in the upper pulmonary vein, but was unable to access the vein so the wire remained in the left atrium for device introduction.The device was advanced and the left disc was deployed, but when it was pulled to the septum, the disc appeared constrained and was sitting high in the atrium.At this point, the patient said something didn't feel right.The disc was reloaded and redeployed, following which, the disc appeared normal and properly apposed the septum.The patient said again that something didn't feel right.The physician then fully deployed and released the device, and the patient was checked for a pericardial effusion using intracardiac echocardiography (ice).No effusion was detected and the delivery catheter and ice catheter were removed.At this point the patient's blood pressure and heart rated dropped.Transthoracic echocardiography was brought in to assess the patient and revealed a pericardial effusion.The effusion was drained and the patient was transferred to the intensive care unit where he was in stable condition.Two days following the procedure, it was reported the patient was doing well and would be discharged.
 
Manufacturer Narrative
Electronic files containing digital cine fluoroscopy runs were received for evaluation.Fluoroscopy images show the gore® cardioform septal occluder being deployed in the left atrium.It is unknown where the tip of the delivery catheter is as no echocardiographic images of this step were provided, and the wire has already been removed.Other images show the depth of the initial deployment relative to the position of the device within the septum; however, without echocardiographic imaging, it is not possible to determine the position of the initial deployment relative to other cardiac structures.Additional procedural fluoroscopic images show the attempts of placing the guidewire in the left upper pulmonary vein and eventually placing the wire in the left atrium for device introduction.Transthoracic echocardiography images provided confirm the pericardial effusion.
 
Manufacturer Narrative
Usage of device - corrected to 'initial use of device'.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
GORE® CARDIOFORM SEPTAL OCCLUDER
Type of Device
TRANSCATHETER, SEPTAL OCCLUDER
Manufacturer (Section D)
W.L. GORE & ASSOCIATES
flagstaff AZ
MDR Report Key7355365
MDR Text Key102970650
Report Number2017233-2018-00181
Device Sequence Number1
Product Code MLV
Combination Product (y/n)N
PMA/PMN Number
P050006
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Type of Report Initial,Followup,Followup
Report Date 04/17/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date12/13/2019
Device Catalogue NumberGSX0025A
Device Lot Number17550283
Was Device Available for Evaluation? No
Initial Date Manufacturer Received Not provided
Initial Date FDA Received03/20/2018
Supplement Dates Manufacturer ReceivedNot provided
Not provided
Supplement Dates FDA Received04/13/2018
04/17/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Life Threatening; Required Intervention;
Patient Age55 YR
Patient Weight78
-
-